A Study of Peginterferon Alfa-2a (40KD) (PEGASYS®) in Participants With Hepatitis B Envelope Antigen (HBeAg) - Positive Chronic Hepatitis B

NCT00436163 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

39

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis B, Chronic

Interventions

DRUG: Peginterferon alfa-2a

Sponsor

Hoffmann-La Roche